These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 15550792)
1. Left atrial diameter is a simple indicator of a deficiency in atrial natriuretic peptide secretion in patients with mitral stenosis: efficacy of postoperative supplementation with synthetic human alpha-atrial natriuretic peptide. Hayashi Y; Ohtani M; Sawa Y; Hiraishi T; Kobayashi Y; Matsuda H J Cardiovasc Pharmacol; 2004 Dec; 44(6):709-17. PubMed ID: 15550792 [TBL] [Abstract][Full Text] [Related]
2. Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis. Nakamura M; Kawata Y; Yoshida H; Arakawa N; Koeda T; Ichikawa T; Funakoshi T; Hiramori K Am Heart J; 1992 Nov; 124(5):1283-8. PubMed ID: 1442497 [TBL] [Abstract][Full Text] [Related]
3. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293 [TBL] [Abstract][Full Text] [Related]
4. Effects of intraoperative administration of atrial natriuretic peptide. Hayashida N; Chihara S; Kashikie H; Tayama E; Yokose S; Akasu K; Aoyagi S Ann Thorac Surg; 2000 Oct; 70(4):1319-26. PubMed ID: 11081892 [TBL] [Abstract][Full Text] [Related]
5. [Postoperative therapy using human atrial natriuretic peptide in cases of valve replacement]. Maeda T; Kitamura M; Kawai A; Hachida M; Aomi S; Endo M; Koyanagi H; Sakomura Y; Matsuda N; Kasanori H Jpn J Thorac Cardiovasc Surg; 1998 Dec; 46(12):1297-304. PubMed ID: 10037839 [TBL] [Abstract][Full Text] [Related]
6. Atrial natriuretic peptide and vasopressin during percutaneous transvenous mitral valvuloplasty and relation to renin-angiotensin-aldosterone system and renal function. Tsai RC; Yamaji T; Ishibashi M; Takaku F; Fu M; Cherng WJ; Inoue K; Hung JS Am J Cardiol; 1990 Apr; 65(13):882-6. PubMed ID: 2138848 [TBL] [Abstract][Full Text] [Related]
7. Decreased plasma brain natriuretic peptide levels after a successful maze procedure. Watanabe M; Murakami M; Furukawa H; Nakahara H; Tanaka H; Sunamori M J Heart Valve Dis; 2003 May; 12(3):287-91. PubMed ID: 12803326 [TBL] [Abstract][Full Text] [Related]
8. Plasma ANP and renin-angiotensin-aldosterone system as new parameters describing the hemodynamics of the circulatory system after implantation of stented or stentless aortic valves. Szafranek A; Jasinski M; Kolowca M; Gemel M; Wos S J Heart Valve Dis; 2006 Sep; 15(5):702-8; discussion 709. PubMed ID: 17044378 [TBL] [Abstract][Full Text] [Related]
9. An integrated study employing histopathological, immunohistocytochemical and radioimmunoassay analyses of atrial natriuretic peptide in the right and left atria in patients with mitral valve disease. Nagata M; Hiroe M; Naruse M; Yu ZX; Sekiguchi M; Hirosawa K; Koyanagi H; Hashimoto A; Endo M; Shizume K Jpn Circ J; 1988 Dec; 52(12):1453-6. PubMed ID: 2977197 [TBL] [Abstract][Full Text] [Related]
10. [Atrial natriuretic peptide in rheumatic mitral valve disease]. Hryniewiecki T; Rawczyńska-Englert I; Orłowska-Baranowska E; Pszona B Pol Arch Med Wewn; 1993 Apr; 89(4):293-7. PubMed ID: 8351229 [TBL] [Abstract][Full Text] [Related]
16. Correlation of tissue selectin expression and hemodynamic parameters in rheumatic mitral valve disease. Tokgözoglu L; Can I; Korkusuz P; Asan E; Ozer N; Demircin M J Heart Valve Dis; 2006 Sep; 15(5):671-8. PubMed ID: 17044373 [TBL] [Abstract][Full Text] [Related]
17. Ratio of preoperative atrial natriuretic peptide to brain natriuretic peptide predicts the outcome of the maze procedure in mitral valve disease. Sato M; Mikamo A; Kurazumi H; Suzuki R; Murakami M; Kobayashi T; Yoshimura K; Hamano K J Cardiothorac Surg; 2013 Feb; 8():32. PubMed ID: 23448148 [TBL] [Abstract][Full Text] [Related]
18. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Matsumoto A; Hirata Y; Momomura S; Suzuki E; Yokoyama I; Sata M; Ohtani Y; Serizawa T Am Heart J; 1995 Jan; 129(1):139-45. PubMed ID: 7817907 [TBL] [Abstract][Full Text] [Related]
19. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578 [TBL] [Abstract][Full Text] [Related]
20. Effects of percutaneous transvenous mitral commissurotomy on levels of plasma atrial natriuretic peptide during exercise. Ishikura F; Nagata S; Akaike M; Tamai J; Miyatake K Am J Cardiol; 1991 Jan; 67(1):74-8. PubMed ID: 1824734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]